News & Events

On June 4, policymakers, healthcare leaders, patient representatives, researchers and industry experts from across Europe gathered at the European Parliament in Brussels to discuss one of the most pressing questions facing European healthcare and innovation policy: how can Europe accelerate patient access to innovation while strengthening its global competitiveness in life sciences?

CSW Therapeutics has reached an important new milestone, having been awarded its second MedTech4Health grant

The Center for Disaster Medicine is relocating to Medicinaregatan 8A, where Sahlgrenska Science Park operates the innovation hub within the property. The premises are located opposite the future Sahlgrenska Life district and bring together activities in research, education, and innovation.

The new cohort brings together startups working across regulatory, therapeutics, drug discovery & development, digital health strengthening the life science and healthtech ecosystem at Sahlgrenska Science Park.

Gothenburg-based Omaia has closed an oversubscribed pre-seed round backed by angel investors, reflecting growing investor interest in women’s health – a historically underfunded area despite significant unmet needs.

Mirno, originally incubated at Co-AX Accelerator at Sahlgrenska Science Park, has won the HealthTech Award 2026 for its virtual patient technology, recognised for advancing the way healthcare professionals train, practise and make clinical decisions.

Vitalis is the Nordic region's leading meeting place for the future of health, care and Sahlgrenska Science Park at Vitalis representing Sweden innovations to showcase future of health innovation.

Germany offers significant opportunities for Swedish MedTech companies, but entering the market requires a strong understanding of the healthcare system, local partnerships, and successful pilot implementation. 

On 4 March, investors, entrepreneurs and industry leaders will gather at Wallenberg Conference Centre, Sahlgrenska Academy, as Life Science Day marks its 10th anniversary.

In the report’s “State of the Industry” section, Emma Hallenberg, Director of Co-Ax Accelerator at Sahlgrenska Science Park, shares insights on the evolving landscape for life science innovation in Gothenburg and Sweden.

Several companies within Sahlgrenska Science Park have recently reached significant milestones, including a strategic acquisition and substantial capital secured to advance late-stage clinical trials in Europe and the United States.

Companies at CO-AX accelerator focusing on important sides of building a startups - Market, Clinical trials, Clinical studies.